Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Chandraratna, RAS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 109 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zang, Y; Beard, RL; Chandraratna, RAS; Kang, JX
      Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells

      CELL DEATH AND DIFFERENTIATION
    2. Wakino, S; Kintscher, U; Kim, S; Jackson, S; Yin, F; Nagpal, S; Chandraratna, RAS; Hsueh, WA; Law, RE
      Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    3. Beard, RL; Klein, ES; Standeven, AM; Escobar, M; Chandraratna, RAS
      Phenylcyclohexene and phenylcyclohexadiene substituted compounds having retinoid antagonist activity

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    4. Koide, T; Downes, M; Chandraratna, RAS; Blumberg, B; Umesono, K
      Active repression of RAR signaling is required for head formation

      GENES & DEVELOPMENT
    5. Wang, Q; Lee, D; Sysounthone, V; Chandraratna, RAS; Christakos, S; Korah, R; Wieder, R
      1,25-dihydroxyvitamin D-3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects

      BREAST CANCER RESEARCH AND TREATMENT
    6. Soprano, DR; Gambone, CJ; Sheikh, SN; Gabriel, JL; Chandraratna, RAS; Soprano, KJ; Kochhar, DM
      The synthetic retinoid AGN 193109 but not retinoic acid elevates CYP1A1 levels in mouse embryos and Hepa-1c1c7 cells

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    7. Thacher, SM; Vasudevan, J; Tsang, KY; Nagpal, S; Chandraratna, RAS
      New dermatological agents for the treatment of psoriasis

      JOURNAL OF MEDICINAL CHEMISTRY
    8. Vuligonda, V; Thacher, SM; Chandraratna, RAS
      Enantioselective syntheses of potent retinoid X receptor ligands: Differential biological activities of individual antipodes

      JOURNAL OF MEDICINAL CHEMISTRY
    9. Samuel, W; Kutty, RK; Nagineni, S; Gordon, JS; Prouty, SM; Chandraratna, RAS; Wiggert, B
      Regulation of stearoyl coenzyme a desaturase expression in human retinal pigment epithelial cells by retinoic acid

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Dawson, MI; Park, JH; Chen, GQ; Chao, WR; Dousman, L; Waleh, N; Hobbs, PD; Jong, L; Toll, L; Zhang, XK; Gu, J; Agadir, A; Merchant, JL; Bai, LC; Verma, AK; Thacher, SM; Chandraratna, RAS; Shroot, B; Hill, DL
      Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: A potential role for trans-RA-induced ZBP-89 in ODC inhibition

      INTERNATIONAL JOURNAL OF CANCER
    11. Hammond, LA; Van Krinks, CH; Durham, J; Tomkins, SE; Burnett, RD; Jones, EL; Chandraratna, RAS; Brown, G
      Antagonists of retinoic acid receptors (RARs) are potent growth inhibitorsof prostate carcinoma cells

      BRITISH JOURNAL OF CANCER
    12. Standeven, AM; Thacher, SM; Yuan, YD; Escobar, M; Vuligonda, V; Beard, RL; Chandraratna, RAS
      Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents

      BIOCHEMICAL PHARMACOLOGY
    13. Nagpal, S; Ghosn, CR; Chandraratna, RAS
      Identification of nuclear receptor interacting proteins using yeast two-hybrid technology - Applications to drug discovery

      STEROID RECEPTOR METHODS: PROTOCOLS AND ASSAYS
    14. Nagpal, S; Chandraratna, RAS
      Recent developments in receptor-selective retinoids

      CURRENT PHARMACEUTICAL DESIGN
    15. Thacher, SM; Vasudevan, J; Chandraratna, RAS
      Therapeutic applications for ligands of retinoid receptors

      CURRENT PHARMACEUTICAL DESIGN
    16. Massaro, GD; Massaro, D; Chan, WY; Clerch, LB; Ghyselinck, N; Chambon, P; Chandraratna, RAS
      Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli

      PHYSIOLOGICAL GENOMICS
    17. Duvic, M; Helekar, B; Schulz, C; Cho, M; DiSepio, D; Hager, C; DiMao, D; Hazarika, P; Jackson, B; Breuer-McHam, J; Young, J; Clayman, G; Lippman, SM; Chandraratna, RAS; Robinson, NA; Deucher, A; Eckert, RL; Nagpal, S
      Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer

      CLINICAL CANCER RESEARCH
    18. Sun, SY; Yue, P; Mao, L; Dawson, MI; Shroot, B; Lamph, WW; Heyman, RA; Chandraratna, RAS; Shudo, K; Hong, WK; Lotan, R
      Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells

      CLINICAL CANCER RESEARCH
    19. Tsonis, PA; Trombley, MT; Rowland, T; Chandraratna, RAS; Del Rio-Tsonis, K
      Role of retinoic acid in lens regeneration

      DEVELOPMENTAL DYNAMICS
    20. Deucher, A; Nagpal, S; Chandraratna, RAS; Di Sepio, D; Robinson, NA; Dashti, SR; Eckert, RL
      The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity

      INTERNATIONAL JOURNAL OF ONCOLOGY
    21. Sun, SY; Yue, P; Chandraratna, RAS; Tesfaigzi, Y; Hong, WK; Lotan, R
      Dual mechanisms of action of the retinoid CD437: Nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells

      MOLECULAR PHARMACOLOGY
    22. Tsukada, M; Schroder, M; Roos, TC; Chandraratna, RAS; Reichert, U; Merk, HF; Orfanos, CE; Zouboulis, CC
      13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    23. Weston, AD; Rosen, V; Chandraratna, RAS; Underhill, TM
      Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways

      JOURNAL OF CELL BIOLOGY
    24. Klein, ES; Wang, JW; Khalifa, B; Gavigan, SA; Chandraratna, RAS
      Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands - Influence of DNA-heterodimer interactions

      JOURNAL OF BIOLOGICAL CHEMISTRY
    25. Kintscher, U; Goetze, S; Wakino, S; Kim, S; Nagpal, S; Chandraratna, RAS; Graf, K; Fleck, E; Hsueh, WA; Law, RE
      Peroxisome proliferator-activated receptor and retinoid X receptor ligandsinhibit monocyte chemotactic protein-1-directed migration of monocytes

      EUROPEAN JOURNAL OF PHARMACOLOGY
    26. DiSepio, D; Chandraratna, RAS; Nagpal, S
      Novel approaches for the treatment of psoriasis

      DRUG DISCOVERY TODAY
    27. Sun, SY; Kurie, JM; Yue, P; Dawson, MI; Shroot, B; Chandraratna, RAS; Hong, WK; Lotan, R
      Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids

      CLINICAL CANCER RESEARCH
    28. Kang, JX; Bell, J; Beard, RL; Chandraratna, RAS
      Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids

      CELL GROWTH & DIFFERENTIATION
    29. Thacher, SM; Nagpal, S; Klein, ES; Arefieg, T; Krasinski, G; DiSepio, D; Agarwal, C; Johnson, A; Eckert, RL; Chandraratna, RAS
      Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: Divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes

      CELL GROWTH & DIFFERENTIATION
    30. Johnson, AT; Wang, LM; Standeven, AM; Escobar, M; Chandraratna, RAS
      Synthesis and biological activity of high-affinity retinoic acid receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY
    31. Vuligonda, V; Lin, Y; Thacher, SM; Standeven, AM; Kochar, DM; Chandraratna, RAS
      A new class of RAR subtype selective retinoids: Correlation of pharmacological effects with receptor activity

      BIOORGANIC & MEDICINAL CHEMISTRY
    32. Vuligonda, V; Standeven, AM; Escobar, M; Chandraratna, RAS
      A new class of potent RAR antagonists: Dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoids

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    33. Johnson, AT; Wang, LM; Gillett, SJ; Chandraratna, RAS
      High affinity retinoic acid receptor antagonists: Analogs of AGN 193109

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    34. Vuligonda, V; Garst, ME; Chandraratna, RAS
      Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    35. Vuligonda, V; Chandraratna, RAS
      A short and efficient synthesis of 4-[2,2-dimethyl-4(tol-4-yl)benzochrom-3-en-7-yl]benzoic acid - A potent retinoic acid receptor antagonist

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    36. Johnson, BS; Chandraratna, RAS; Heyman, RA; Allegretto, EA; Mueller, L; Collins, SJ
      Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha 403 heterodimers is developmentally regulated during myeloid differentiation

      MOLECULAR AND CELLULAR BIOLOGY
    37. Tsukui, T; Capdevila, J; Tamura, K; Ruiz-Lozano, P; Rodriguez-Esteban, C; Yonei-Tamura, S; Magallon, J; Chandraratna, RAS; Chien, K; Blumberg, B; Evans, RM; Belmonte, JCI
      Multiple left-right asymmetry defects in Shh(-/-) mutant mice unveil a convergence of the Shh and retinoic acid pathways in the control of Lefty-1

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    38. Nagpal, S; Ghosn, C; DiSepio, D; Molina, Y; Sutter, M; Klein, ES; Chandraratna, RAS
      Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    39. Koyama, E; Golden, EB; Kirsch, T; Adams, SL; Chandraratna, RAS; Michaille, JJ; Pacifici, M
      Retinoid signaling is required for chondrocyte maturation and endochondralbone formation during limb skeletogenesis

      DEVELOPMENTAL BIOLOGY
    40. Shalita, AR; Chalker, DK; Griffith, RF; Herbert, AA; Hickman, JG; Maloney, JM; Miller, BH; Tschen, EH; Chandraratna, RAS; Gibson, JR; Lew-Kaya, DA; Lue, JC; Sefton, J
      Tazarotene gel is safe and effective in the treatment of acne vulgaris: A multicenter, double-blind, vehicle-controlled study

      CUTIS
    41. Zhu, WY; Jones, CS; Amin, S; Matsukuma, K; Haque, M; Vuligonda, V; Chandraratna, RAS; De Luca, LM
      Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells

      CANCER RESEARCH
    42. Johnson, A; Chandraratna, RAS
      Novel retinoids with receptor selectivity and functional selectivity

      BRITISH JOURNAL OF DERMATOLOGY
    43. Agarwal, C; Lambert, A; Chandraratna, RAS; Rorke, EA; Eckert, RL
      Vitamin D regulates human ectocervical epithelial cell proliferation and insulin-like growth factor-binding protein-3 level

      BIOLOGY OF REPRODUCTION
    44. KOCHHAR DM; JIANG H; PENNER JD; JOHNSON AT; CHANDRARATNA RAS
      THE USE OF A RETINOID RECEPTOR ANTAGONIST IN A NEW MODEL TO STUDY VITAMIN-A-DEPENDENT DEVELOPMENTAL EVENTS

      The International journal of developmental biology
    45. CHANDRARATNA RAS
      RATIONAL DESIGN OF RECEPTOR-SELECTIVE RETINOIDS

      Journal of the American Academy of Dermatology
    46. CHANDRARATNA RAS
      FUTURE-TRENDS - A NEW-GENERATION OF RETINOIDS

      Journal of the American Academy of Dermatology
    47. LEBWOHL M; AST E; CALLEN JP; CULLEN SI; HONG SR; KULPSHORTEN CL; LOWE NJ; PHILLIPS TJ; ROSEN T; WOLF DI; QUELL JM; SEFTON J; LUE JC; GIBSON JR; CHANDRARATNA RAS
      ONCE-DAILY TAZAROTENE GEL VERSUS TWICE-DAILY FLUOCINONIDE CREAM IN THE TREATMENT OF PLAQUE PSORIASIS

      Journal of the American Academy of Dermatology
    48. KANG JX; BELL J; LEAF A; BEARD RL; CHANDRARATNA RAS
      RETINOIC ACID ALTERS THE INTRACELLULAR TRAFFICKING OF THE MANNOSE-6-PHOSPHATE INSULIN-LIKE-GROWTH-FACTOR-II RECEPTOR AND LYSOSOMAL-ENZYMES

      Proceedings of the National Academy of Sciences of the United Statesof America
    49. DiSepio, D; Ghosn, C; Eckert, RL; Deucher, A; Robinson, N; Duvic, M; Chandraratna, RAS; Nagpal, S
      Identification and characterization of a retinoid-induced class II tumor suppressor growth regulatory gene

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    50. ANGULO A; CHANDRARATNA RAS; LEBLANC JF; GHAZAL P
      LIGAND INDUCTION OF RETINOIC ACID RECEPTORS ALTERS AN ACUTE INFECTIONBY MURINE CYTOMEGALOVIRUS

      Journal of virology
    51. KRUEGER GG; DRAKE LA; ELIAS PM; LOWE NJ; GUZZO C; WEINSTEIN GD; LEWKAYA DA; LUE JC; SEFTON J; CHANDRARATNA RAS
      THE SAFETY AND EFFICACY OF TAZAROTENE GEL, A TOPICAL ACETYLENIC RETINOID, IN THE TREATMENT OF PSORIASIS

      Archives of dermatology
    52. BEARD RL; TENG M; COLON DF; DUONG TT; THACHER SM; AREFIEG T; CHANDRARATNA RAS
      SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 1,2,3,4-TETRAHYDROQUINOLINE AND 3,4-(1H)-DIHYDROQUINOLIN-2-ONE ANALOGS OF RETINOIC ACID

      Bioorganic & medicinal chemistry letters
    53. STANDEVEN AM; TENG M; CHANDRARATNA RAS
      LACK OF INVOLVEMENT OF RETINOIC ACID RECEPTOR-ALPHA IN RETINOID-INDUCED SKIN IRRITATION IN HAIRLESS MICE

      Toxicology letters
    54. NAGPAL S; CAI J; ZHENG T; PATEL S; MASOOD R; LIN GY; FRIANT S; JOHNSON A; SMITH DL; CHANDRARATNA RAS; GILL PS
      RETINOID ANTAGONISM OF NF-IL6 - INSIGHT INTO THE MECHANISM OF ANTIPROLIFERATIVE EFFECTS OF RETINOIDS IN KAPOSIS-SARCOMA

      Molecular and cellular biology
    55. CHANDRARATNA RAS
      TAZAROTENE - THE FIRST RECEPTOR-SELECTIVE TOPICAL RETINOID FOR THE TREATMENT OF PSORIASIS

      Journal of the American Academy of Dermatology
    56. DUVIC M; NAGPAL S; ASANO AT; CHANDRARATNA RAS
      MOLECULAR MECHANISMS OF TAZAROTENE ACTION IN PSORIASIS

      Journal of the American Academy of Dermatology
    57. WEINSTEIN GD; KRUEGER GG; LOWE NJ; DUVIC M; FRIEDMAN DJ; JEGASOTHY BV; JORIZZO JL; SHMUNES E; TSCHEN EH; LEWKAYA DA; LUE JC; SEFTON J; GIBSON JR; CHANDRARATNA RAS
      TAZAROTENE GEL, A NEW RETINOID, FOR TOPICAL THERAPY OF PSORIASIS - VEHICLE-CONTROLLED STUDY OF SAFETY, EFFICACY, AND DURATION OF THERAPEUTIC EFFECT

      Journal of the American Academy of Dermatology
    58. THACHER SM; STANDEVEN AM; ATHANIKAR J; KOPPER S; CASTILLEJA O; ESCOBAR M; BEARD RL; CHANDRARATNA RAS
      RECEPTOR SPECIFICITY OF RETINOID-INDUCED EPIDERMAL HYPERPLASIA - EFFECT OF RXR-SELECTIVE AGONISTS AND CORRELATION WITH TOPICAL IRRITATION

      The Journal of pharmacology and experimental therapeutics
    59. TENG M; DUONG TT; JOHNSON AT; KLEIN ES; WANG LM; KHALIFA B; CHANDRARATNA RAS
      IDENTIFICATION OF HIGHLY POTENT RETINOIC ACID RECEPTOR ALPHA-SELECTIVE ANTAGONISTS

      Journal of medicinal chemistry
    60. NAGPAL S; PATEL S; JACOBE H; DISEPIO D; GHOSN C; MALHOTRA M; TENG M; DUVIC M; CHANDRARATNA RAS
      TAZAROTENE-INDUCED-GENE-2 (TIG2), A NOVEL RETINOID-RESPONSIVE GENE INSKIN

      Journal of investigative dermatology
    61. HAZARIKA P; DUONG DMT; HAGER C; HAKINZADEH M; SARRIS A; NAGPAL S; THACHER S; CHANDRARATNA RAS; DUVIC M
      INTERFERON-INDUCIBLE PROTEIN-10 IS REDUCED BY TREATMENT WITH RAR SPECIFIC RETINOIDS IN PSORIASIS AND KERATINOCYTE CULTURES

      Journal of investigative dermatology
    62. NAGPAL S; GHOSN C; DISEPIO D; MALHOTRA M; PATEL S; JACOBE H; HAGER C; THACHER S; DUVIC M; CHANDRARATNA RAS
      TAZAROTENE AN RAR SELECTIVE RETINOID, AFFECTS THE EXPRESSION OF GENESASSOCIATED WITH ABNORMAL DIFFERENTIATION, HYPERPROLIFERATION AND INFLAMMATION

      Journal of investigative dermatology
    63. DISEPIO D; MALHOTRA M; CHANDRARATNA RAS; NAGPAL S
      RETINOID INHIBITION OF MRP-8 VIA ANTAGONISM OF NF-IL6 ENHANCER ACTIVITY - A NOVEL MECHANISM OF GENE-REGULATION

      Journal of investigative dermatology
    64. KLEIN ES; PINO ME; JOHNSON AT; NAGPAL S; THACHER S; KRASINSKI G; CHANDRARATNA RAS
      IDENTIFICATION OF RETINOIC ACID RECEPTOR INVERSE AGONISTS AND THEIR POTENTIAL USE AS THERAPEUTIC AGENTS

      Journal of investigative dermatology
    65. AGARWAL C; CHANDRARATNA RAS; RORKE EA; ECKERT RL
      VITAMIN-D SUPPRESSES HUMAN ECTOCERVICAL KERATINOCYTE PROLIFERATION AND INCREASES INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 (IGFBP-3)

      Journal of investigative dermatology
    66. NAGPAL S; DISEPIO D; MALHOTRA M; GHOSN C; DUVIC M; CHANDRARATNA RAS
      ANTAGONISM OF TRANSCRIPTION FACTOR ACTION - A MAJOR-MODE OF THERAPEUTIC ACTION OF RETINOIDS

      Journal of investigative dermatology
    67. HEMBREE JR; AGARWAL C; EFIMOVA T; CHANDRARATNA RAS; ECKERT RL
      INTERFERON REGULATION OF PROLIFERATION AND INSULIN-LIKE GROWTH-FACTORBINDING-PROTEIN EXPRESSION IN HUMAN ECTOCERVICAL KERATINOCYTES

      Journal of investigative dermatology
    68. HAGER C; DIMAIO D; MAYS S; ANGEL T; CUNNINGHAM MA; LEDBETTER L; SEFTON J; THACHER SM; NAGPAL S; CHANDRARATNA RAS; DUVIC M
      TAZAROTENE 0.1-PERCENT GEL IS ASSOCIATED WITH ALTERATIONS IN MARKERS OF EPIDERMAL DIFFERENTIATION AND INFLAMMATION IN PSORIATIC PLAQUES

      Journal of investigative dermatology
    69. CHANDRARATNA RAS; THACHER SM; KLEIN ES
      RETINOID AGONISTS AND INVERSE AGONISTS - A NEW-GENERATION

      Journal of investigative dermatology
    70. DISEPIO D; MALHOTRA M; CHANDRARATNA RAS; NAGPAL S
      RETINOIC ACID RECEPTOR-NUCLEAR FACTOR-INTERLEUKIN-6 ANTAGONISM - A NOVEL MECHANISM OF RETINOID-DEPENDENT INHIBITION OF A KERATINOCYTE HYPERPROLIFERATIVE DIFFERENTIATION MARKER

      The Journal of biological chemistry
    71. SUN SY; YUE P; DAWSON MI; SHROOT B; MICHEL S; LAMPH WW; HEYMAN RA; TENG M; CHANDRARATNA RAS; SHUDO K; HONG WK; LOTAN R
      DIFFERENTIAL-EFFECTS OF SYNTHETIC NUCLEAR RETINOID RECEPTOR-SELECTIVERETINOIDS ON THE GROWTH OF HUMAN NONSMALL CELL LUNG-CARCINOMA CELLS

      Cancer research
    72. FITZGERALD P; TENG M; CHANDRARATNA RAS; HEYMAN RA; ALLEGRETTO EA
      RETINOIC ACID RECEPTOR-ALPHA EXPRESSION CORRELATES WITH RETINOID-INDUCED GROWTH-INHIBITION OF HUMAN BREAST-CANCER CELLS REGARDLESS OF ESTROGEN-RECEPTOR STATUS

      Cancer research
    73. STANDEVEN AM; ESCOBAR M; BEARD RL; YUAN YD; CHANDRARATNA RAS
      MITOGENIC EFFECT OF RETINOID-X-RECEPTOR AGONISTS IN RAT-LIVER

      Biochemical pharmacology
    74. AGARWAL C; CHANDRARATNA RAS; TENG M; NAGPAL S; RORKE EA; ECKERT RL
      DIFFERENTIAL REGULATION OF HUMAN ECTOCERVICAL EPITHELIAL-CELL LINE PROLIFERATION AND DIFFERENTIATION BY RETINOID-X-RECEPTOR-SPECIFIC AND RETINOIC ACID RECEPTOR-SPECIFIC RETINOIDS

      Cell growth & differentiation
    75. NAGPAL S; THACHER SM; PATEL S; FRIANT S; MALHOTRA M; SHAFER J; KRASINSKI G; ASANO AT; TENG M; DUVIC M; CHANDRARATNA RAS
      NEGATIVE REGULATION OF 2 HYPERPROLIFERATIVE KERATINOCYTE DIFFERENTIATION MARKERS BY A RETINOIC ACID RECEPTOR-SPECIFIC RETINOID - INSIGHT INTO THE MECHANISM OF RETINOID ACTION IN PSORIASIS

      Cell growth & differentiation
    76. VULIGONDA V; LIN Y; CHANDRARATNA RAS
      SYNTHESIS OF HIGHLY POTENT RXR-SPECIFIC RETINOIDS - THE USE OF A CYCLOPROPYL GROUP AS A DOUBLE-BOND ISOSTERE

      Bioorganic & medicinal chemistry letters
    77. STANDEVEN AM; DAVIES PJA; CHANDRARATNA RAS; MADER DR; JOHNSON AT; THOMAZY VA
      RETINOID-INDUCED EPIPHYSEAL PLATE CLOSURE IN GUINEA-PIGS

      Fundamental and applied toxicology
    78. STANDEVEN AM; BEARD RL; JOHNSON AT; BOEHM MF; ESCOBAR M; HEYMAN RA; CHANDRARATNA RAS
      RETINOID-INDUCED HYPERTRIGLYCERIDEMIA IN RATS IS MEDIATED BY RETINOICACID RECEPTORS

      Fundamental and applied toxicology
    79. NAGY L; THOMAZY VA; CHANDRARATNA RAS; HEYMAN RA; DAVIES PJA
      RETINOID-REGULATED EXPRESSION OF BCL-2 AND TISSUE TRANSGLUTAMINASE DURING THE DIFFERENTIATION AND APOPTOSIS OF HUMAN MYELOID-LEUKEMIA (HL-60) CELLS

      Leukemia research
    80. STANDEVEN AM; JOHNSON AT; ESCOBAR R; CHANDRARATNA RAS
      SPECIFIC ANTAGONIST OF RETINOID TOXICITY IN MICE

      Toxicology and applied pharmacology
    81. VULIGONDA V; LIN Y; CHANDRARATNA RAS
      SELECTIVE CONVERSION OF ALPHA-TETRALONES TO DIHYDRONAPHTHALENES

      Tetrahedron letters
    82. JOHNSON AT; KLEIN ES; WANG LM; PINO ME; CHANDRARATNA RAS
      IDENTIFICATION OF RETINOIC ACID RECEPTOR-BETA SUBTYPE-SPECIFIC AGONISTS

      Journal of medicinal chemistry
    83. BEARD RL; COLON DF; SONG TK; DAVIES PJA; KOCHHAR DM; CHANDRARATNA RAS
      SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF RETINOID-X RECEPTOR-SELECTIVE DIARYL SULFIDE ANALOGS OF RETINOIC ACID

      Journal of medicinal chemistry
    84. TENG M; DUONG TT; KLEIN ES; PINO ME; CHANDRARATNA RAS
      IDENTIFICATION OF A RETINOIC ACID RECEPTOR-ALPHA SUBTYPE-SPECIFIC AGONIST

      Journal of medicinal chemistry
    85. NAGPAL S; PATEL S; ASANO AT; JOHNSON A; DUVIC M; CHANDRARATNA RAS
      TIG1 AND TIG2 (TAZAROTENE INDUCED GENE-1 AND GENE-2) ARE NOVEL RETINOIC ACID RECEPTOR-RESPONSIVE GENES IN SKIN

      Journal of investigative dermatology
    86. AGARWAL C; CHANDRARATNA RAS; JOHNSON AT; RORKE EA; ECKERT RL
      AGN193109 IS A PURE ANTAGONIST OF RETINOID ACTION IN HUMAN ECTOCERVICAL KERATINOCYTES

      Journal of investigative dermatology
    87. HEMBREE JR; AGARWAL C; BAARD RL; CHANDRARATNA RAS; ECKERT RL
      RXR-SPECIFIC RETINOIDS INHIBIT THE ABILITY OF RAR-SPECIFIC RETINOIDS TO INCREASE THE LEVEL OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-9 (IGFBP-3) IN HUMAN ECTOCERVICAL EPITHELIAL-CELLS

      Journal of investigative dermatology
    88. THACHER SM; KRASINSKI G; MALHOTRA M; DUVIC M; NAGPAL S; CHANDRARATNA RAS
      COORDINATE REGULATION OF KERATINOCYTE DIFFERENTIATION MARKERS BY RETINOIDS IN CELL-CULTURE AND IN PSORIASIS

      Journal of investigative dermatology
    89. CHANDRARATNA RAS; KLEIN ES; JOHNSON AT; ESCOBAR M; STANDEVEN AM
      THE USE OF A RETINOIC ACID RECEPTOR ANTAGONIST TO PREVENT RETINOID-INDUCED SKIN IRRITATION

      Journal of investigative dermatology
    90. NAGPAL S; PATEL S; ASANO AT; JOHNSON AT; DUVIC M; CHANDRARATNA RAS
      TAZAROTENE-INDUCED GENE-1 (TIG1), A NOVEL RETINOIC ACID RECEPTOR-RESPONSIVE GENE IN SKIN

      Journal of investigative dermatology
    91. NAGY L; SAYDAK M; SHIPLEY N; LU S; BASILION JP; YAN ZH; SYKA P; CHANDRARATNA RAS; STEIN JP; HEYMAN RA; DAVIES PJA
      IDENTIFICATION AND CHARACTERIZATION OF A VERSATILE RETINOID RESPONSE ELEMENT (RETINOIC ACID RECEPTOR RESPONSE ELEMENT-RETINOID-X-RECEPTOR RESPONSE ELEMENT) IN THE MOUSE-TISSUE TRANSGLUTAMINASE GENE PROMOTER

      The Journal of biological chemistry
    92. AGARWAL C; CHANDRARATNA RAS; JOHNSON AT; RORKE EA; ECKERT RL
      AGN193109 IS A HIGHLY EFFECTIVE ANTAGONIST OF RETINOID ACTION IN HUMAN ECTOCERVICAL EPITHELIAL-CELLS

      The Journal of biological chemistry
    93. KOCHHAR DM; JIANG H; PENNERA JD; BEARD RL; CHANDRARATNA RAS
      DIFFERENTIAL TERATOGENIC RESPONSE OF MOUSE EMBRYOS TO RECEPTOR-SELECTIVE ANALOGS OF RETINOIC ACID

      Chemico-biological interactions
    94. HEMBREE JR; AGARWAL C; BEARD RL; CHANDRARATNA RAS; ECKERT RL
      RETINOID-X RECEPTOR-SPECIFIC RETINOIDS INHIBIT THE ABILITY OF RETINOIC ACID RECEPTOR-SPECIFIC RETINOIDS TO INCREASE THE LEVEL OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IN HUMAN ECTOCERVICAL EPITHELIAL-CELLS

      Cancer research
    95. CHANDRARATNA RAS
      TAZAROTENE - FIRST OF A NEW-GENERATION OF RECEPTOR-SELECTIVE RETINOIDS

      British journal of dermatology
    96. KOCHHAR DM; JIANG H; PENNER JD; JOHNSON AP; CHANDRARATNA RAS
      INDISPENSABLE ROLE OF VITAMIN-A SIGNALING IN NORMAL VERTEBRATE DEVELOPMENT

      Molecular biology of the cell
    97. CHANDRARATNA RAS; GILLETT SJ; SONG TK; ATTARD J; VULIGONDA S; GARST ME; AREFIEG T; GIL DW; WHEELER L
      SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF CONFORMATIONALLY RESTRICTED, ACETYLENIC RETINOID ANALOGS

      Bioorganic & medicinal chemistry letters
    98. BEARD RL; COLON DF; KLEIN ES; VORSE KA; CHANDRARATNA RAS
      DIFFERENTIAL RXR AND RAR ACTIVITY OF STILBENE RETINOID ANALOGS BEARING THIAZOLE AND IMIDAZOLE CARBOXYLIC-ACIDS

      Bioorganic & medicinal chemistry letters
    99. NAGY L; THOMAZY VA; SHIPLEY GL; FESUS L; LAMPH W; HEYMAN RA; CHANDRARATNA RAS; DAVIES PJA
      ACTIVATION OF RETINOID-X RECEPTORS INDUCES APOPTOSIS IN HL-60 CELL-LINES

      Molecular and cellular biology
    100. CHANDRARATNA RAS; HENRY E; ATTARD J; GILLETT SJ; SONG T; GARST ME; NAGPAL S; ATHANIKAR J; AREFIEG T; GIL DW; WHEELER LA; LEWKAYA D; SEFTON J
      DEVELOPMENT OF RAR SUBTYPE-SELECTIVE RETINOIDS FOR DERMATOLOGICAL DISEASES

      European journal of medicinal chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 06:34:29